Herpes simplex virus-2 and HIV among noninjecting drug users in New York City

Sexually Transmitted Diseases

Volumn 34, Issue 11, 2007, Pages 923-927

  Des Jarlais, Don C ^a   Hagan, Holly ^b   Arasteh, Kamyar ^a   McKnight, Courtney ^a   Perlman, David ^a   Friedman, Samuel R ^b  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DIAMORPHINE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG DETOXIFICATION; DRUG USE; FEMALE; HEALTH PROGRAM; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; SEROPREVALENCE; SEX DIFFERENCE; SMOKING; STRUCTURED INTERVIEW; UNITED STATES;

ADULT; COCAINE; FEMALE; HEROIN; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HUMANS; MALE; NEW YORK CITY; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SUBSTANCE-RELATED DISORDERS;

EID: 37349020961     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3180ca9647     Document Type: Article

References (23)

1. Celum C, Robinson N, Cohen M. Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antivirual therapy on transmission and acquisition of HIV type 1 infection. J Infect Dis 2005; 191:S107-S114.
2. Strick L, Wald A, Celum C. Management of herpes simplex virus type 2 infection in HIV type1-infected persons. Clin Infect Dis 2006; 43:347-356.
3. Freeman E, Weiss H, Glynn J, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: Systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20:73-83.
4. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: A meta-analysis. J Infect Dis 2002; 185:45-52.
5. Hwang L, Ross M, Zack C, et al. Prevalence of sexually transmitted infections and associated risk factors among populations of drug users. Clin Infect Dis 2000; 31:920-926.
6. Ross M, Hwang L, Zack C, et al. Sexual risk behaviors and STIs in drug abuse treatment populations whose drug of choice is crack cocaine. Int J STD AIDS 2002; 13:769-774.
7. Plitt S, Sherman S, Strathdee S, et al. Herpes simplex virus 2 and syphilis among drug users in Baltimore, Maryland. Sex Transm Infect 2005; 81:248-253.
8. Des Jarlais DC, Friedman SR, Novick DM, et al. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA 1989; 261:1008-1012.
9. Maslow CB, Friedman SR, Perlis TE, et al. Changes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990-1999. Am J Public Health 2002; 92:382-384.
10. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004; 159:702-706.
11. Agresti A. An Introduction to Categorical Data Analysis. New York: Wiley, 1996.
12. SAS. SAS/STAT® User's Guide, Version 9.1. Version 8 ed. Cary, North Carolina: SAS Institute, 2004.
13. Des Jarlais D, Arasteh K, Perlis T, et al. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City: A new stage in a very large HIV epidemic. AIDS 2007; 21:231-235.
14. Friedman S, Lieb S, Tempalski B, et al. HIV among injection drug users in large US metropolitan areas, 1998. J Urban Health 2005; 82:434-445.
15. Golub A, Johnson B. The new heroin users among Manhattan arrestees: Variations by race/ethnicity and mode of consumption. J Psychoactive Drugs 2005; 37:51-62.
16. New York City Department of Health and Mental Hygiene Website: www.nyc.gov. New York: NYC DOH, 2007.
17. Reynolds S, Risbud A, Shepherd M, et al. Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. J Infect Dis 2003; 187:1513-1521.
18. Kaul R, Kimani J, Nagelkerke N, et al. Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: A randomized controlled trial. JAMA 2004; 291:2555-2562.
19. Ross M, Wodak A, Gold J. Sexual behavior in injecting drug users. J Psychol Human Sex 1992; 5:89-104.
20. Friedman SR, Flom PL, Kottiri BJ, et al. Drug use patterns and infection with sexually transmissible agents among young adults in a high-risk neighborhood in New York City. Addiction 2003; 98:159-169.
21. Des Jarlais DC, Perlis T, Arasteh K, et al. "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001. J Acquir Immune Defic Syndr 2004; 35:158-166.
22. Marks G, Crepaz N, Senterfitt JW, et al. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: Implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005; 39:446-453.
23. Schackman B, Gebo K, Walensky R, et al. The lifetime cost of current human immunodeficiency virus care in the United States. Med Care 2006; 44:990-997.